In an 83‑year‑old patient allergic to penicillin and metronidazole who presents with body aches, dizziness, cough, crackles and wheezes, with a negative chest X‑ray and negative influenza and COVID‑19 tests, what antibiotic and additional treatments should be prescribed?

Antibiotic and Treatment Recommendations for 83-Year-Old with Respiratory Symptoms

Given the penicillin allergy, start a respiratory fluoroquinolone (levofloxacin 750 mg daily or moxifloxacin 400 mg daily) as monotherapy for presumed community-acquired pneumonia (CAP), despite the negative chest X-ray, because the clinical presentation with crackles, wheezes, cough, and systemic symptoms in an elderly patient warrants empirical antibacterial coverage. 1

Antibiotic Selection Rationale

Why Antibiotics Are Indicated Despite Negative X-ray

• Clinical pneumonia can exist without radiographic findings, particularly in elderly patients who may have early disease, dehydration, or atypical presentations 1
• The combination of respiratory symptoms (cough, crackles, wheezes), systemic symptoms (body aches), and negative viral testing creates a clinical picture consistent with bacterial CAP 1
• Empirical antibacterial therapy is proven to save lives in CAP, as bacterial causes are associated with the highest mortality 1

Optimal Antibiotic Choice for Penicillin-Allergic Patients

For low-risk inpatients with penicillin allergy, respiratory fluoroquinolones (levofloxacin or moxifloxacin) are recommended as monotherapy because they provide coverage against the key bacterial pathogens: Streptococcus pneumoniae, Haemophilus influenzae, Chlamydia pneumoniae, and Staphylococcus aureus 1

Alternative Options if Fluoroquinolones Are Contraindicated:

• Azithromycin 500 mg day 1, then 250 mg daily for 4 days (macrolide monotherapy) 1
• Doxycycline 100 mg twice daily 1
• Third- or fourth-generation cephalosporins (ceftriaxone 1-2g daily or cefepime 1-2g every 8-12 hours) can be used safely in penicillin-allergic patients, as cross-reactivity is approximately 1% and negligible with dissimilar side chains 1, 2, 3

Critical Caveat About Cephalosporin Use

• Cephalosporins with dissimilar R1 side chains to penicillin can be administered safely in patients with immediate-type penicillin allergy, regardless of severity 1
• Cefazolin does not share side chains with currently available penicillins and is safe 1
• The cross-reactivity rate between penicillins and cephalosporins is only ~1%, far lower than the historically cited 10% 2
• In a large retrospective review, cefepime, ceftriaxone, and meropenem showed only 6% allergic reactions (mostly mild rash) in penicillin-allergic patients 3

Additional Essential Treatments

Symptomatic Management

• Antipyretics/analgesics for body aches: Acetaminophen 650-1000 mg every 6 hours as needed (preferred over NSAIDs, which are not recommended as adjunctive therapy in severe respiratory infections) 1
• Bronchodilators for wheezing: Albuterol inhaler 2 puffs every 4-6 hours as needed, or nebulized albuterol 2.5 mg every 4-6 hours 1
• Hydration: Encourage oral fluids; consider IV fluids if patient shows signs of dehydration contributing to dizziness

Monitoring and Diagnostic Considerations

• Obtain blood and sputum cultures if available before starting antibiotics, particularly in elderly patients at higher risk for complications 1
• Monitor for clinical improvement within 48-72 hours; if no improvement, consider chest CT (more sensitive than X-ray) or alternative diagnoses 1
• Procalcitonin testing could help limit antibiotic overuse if available, though not required for initial management 1

What NOT to Do

• Do NOT use antibiotics empirically if bacterial co-infection is unlikely - however, in this case with crackles and systemic symptoms, bacterial infection is likely 1
• Do NOT add corticosteroids - there is a conditional recommendation against corticosteroids in severe respiratory infections without specific indication 1, 4
• Do NOT use macrolide antibiotics alone for severe disease - they are insufficient as monotherapy for high-risk patients 1

Duration and Follow-up

• Typical treatment duration is 5-7 days for uncomplicated CAP in elderly patients 1
• Reassess at 48-72 hours: If improving, continue current regimen; if worsening, consider hospitalization and broader coverage 1
• Address dizziness: Evaluate for orthostatic hypotension, dehydration, or medication side effects as contributing factors